The roles of BDNF, pCREB and Wnt3a in the latent period preceding activation of progenitor cell mitosis in the adult dentate gyrus by fluoxetine.
The formation of new neurons continues into adult life in the dentate gyrus of the rat hippocampus, as in many other species. Neurogenesis itself turns out to be highly labile, and is regulated by a number of factors. One of these is the serotoninergic system: treatment with drugs (such as the SSRI fluoxetine) markedly stimulates mitosis in the progenitor cells of the dentate gyrus. But this process has one remarkable feature: it takes at least 14 days of continuous treatment to be effective. This is despite the fact that the pharmacological action of fluoxetine occurs within an hour or so of first administration. This paper explores the role of BDNF in this process, using the effect of a Trk antagonist (K252a) on the labelling of progenitor cells with the mitosis marker Ki67 and the associated expression of pCREB and Wnt3a. These experiments show that (i) Fluoxetine increased Ki67 counts, as well as pCREB and Wnt3a expression in the dentate gyrus. The action of fluoxetine on the progenitor cells and on pCREB (but not Wnt3a) depends upon Trk receptor activation, since it was prevented by icv infusion of K252a. (ii) These receptors are required for both the first 7 days of fluoxetine action, during which no apparent change in progenitor mitosis occurs, as well as the second 7 days. Increased pCREB was always associated with progenitor cell mitosis, but Wnt3a expression may be necessary but not sufficient for increased progenitor cell proliferation. These results shed new light on the action of fluoxetine on neurogenesis in the adult dentate gyrus, and have both clinical and experimental interest.
Department of Physiology, Cambridge Centre for Brain Repair, University of Cambridge, Cambridge, United Kingdom.
Scarlett B
SB
Pinnock
Alastair M
AM
Blake
Nicola J
NJ
Platt
Joe
J
Herbert
D000818:Animals; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics / Q000502:physiology*; D002227:Carbazoles / Q000494:pharmacology; D017362:Cyclic AMP Response Element-Binding Protein / Q000502:physiology*; D018891:Dentate Gyrus / Q000166:cytology / Q000187:drug effects*; D005473:Fluoxetine / Q000494:pharmacology*; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D026121:Indole Alkaloids / Q000494:pharmacology; D008938:Mitosis / Q000187:drug effects*; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology*; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects*; D051153:Wnt Proteins / Q000502:physiology*; D060508:Wnt3 Protein
D019208:Brain-Derived Neurotrophic Factor; D002227:Carbazoles; D017362:Cyclic AMP Response Element-Binding Protein; D005473:Fluoxetine; D026121:Indole Alkaloids; D012333:RNA, Messenger; D017367:Selective Serotonin Reuptake Inhibitors; D051153:Wnt Proteins; D060508:Wnt3 Protein; C049985:staurosporine aglycone